LYCA

Lycia Therapeutics, Inc. - Common Stock (LYCA)

About Lycia Therapeutics, Inc. - Common Stock (LYCA)

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.

Details

Daily high

$28.00

Daily low

$25.06

Price at open

$26.51

52 Week High

$36.49

52 Week Low

$18.00

Market cap

1.5B

Dividend yield

Volume

293,144

Avg. volume

1.1M

P/E ratio

Lycia Therapeutics, Inc. - Common Stock News